FreeTender
Accepting bidstenderRussia

Норэпинефрин, Эноксапарин Натрия, Циклофосфамид, Пембролизумаб (2027 г.)

Norepinephrine, Enoxaparin Sodium, Cyclophosphamide, Pembrolizumab (2027)English, machine translated

Issued by ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ МОСКОВСКОЙ ОБЛАСТИ "МОСКОВСКИЙ ОБЛАСТНОЙ ОНКОЛОГИЧЕСКИЙ КЛИНИЧЕСКИЙ ЦЕНТР" · via Russia — other ETPs: ТЭК-Торг, Фабрикант, ЕАТ, OTC, ГПБ (via B2B-Center/OTC aggregator)

Verify & apply on the official portal →
Published
30 Oct 2026
Closes
9 Nov 2026, 07:00 UTC
Value
RUB 2,304,470
Reference
0348200041326000552
Location
Московская область, Russia
Sector
Healthcare & Pharma
Type
goods

At a glance

ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ МОСКОВСКОЙ ОБЛАСТИ "МОСКОВСКИЙ ОБЛАСТНОЙ ОНКОЛОГИЧЕСКИЙ КЛИНИЧЕСКИЙ ЦЕНТР" in Russia has published a tender in healthcare & pharma: “Норэпинефрин, Эноксапарин Натрия, Циклофосфамид, Пембролизумаб (2027 г.)”. Submissions close on 9 November 2026, 10 days from today. The stated value is RUB 2,304,470. Quote reference 0348200041326000552 in any correspondence with the buyer. FreeTender has recorded 78 notices from this buyer since 2026, 43 of them currently open. There are 22,702 open healthcare & pharma notices in Russia on FreeTender. Bids are submitted to the buyer through Russia — other ETPs: ТЭК-Торг, Фабрикант, ЕАТ, OTC, ГПБ (via B2B-Center/OTC aggregator), not through FreeTender.

English summary

Machine translated from Russian by FreeTender. The original notice below is the binding text.

Subject matter of procurement: 1. cyclophosphamide powder for the preparation of a solution for intravenous administration of 500 mg (OKPD2 21.20.10.211 - Antitumor drugs), 25 000 mg 2. enoxaparin sodium injection solution 10,000 anti-ha ed / ml (OKPD2 21.20.10.131 - Anticoagulants), 4000 ml 3. pembrolizumab concentrate for the preparation of a solution for infusions of 25 mg / ml (OKPD2 21.20.10.211 - Antitumor drugs), 4 ml 4. norepinephrine, concentrate for the preparation of a solution for intravenous administration of 2 mg / ml (OKPD2 21.20.10.141 - Preparations for the treatment of heart disease), 2000 ml Law: 44-FZ.

Details

НОРЭПИНЕФРИН, ЭНОКСАПАРИН НАТРИЯ, ЦИКЛОФОСФАМИД, ПЕМБРОЛИЗУМАБ (2027 г.)

Объект закупки:

1. циклофосфамид порошок для приготовления раствора для внутривенного введения 500 мг (ОКПД2 21.20.10.211 – Препараты противоопухолевые), 25 000 мг 2. эноксапарин натрия раствор для инъекций 10000 анти-ха ед/мл (ОКПД2 21.20.10.131 – Антикоагулянты), 4 000 мл 3. пембролизумаб концентрат для приготовления раствора для инфузий 25 мг/мл (ОКПД2 21.20.10.211 – Препараты противоопухолевые), 4 мл 4. норэпинефрин, концентрат для приготовления раствора для внутривенного введения 2 мг/мл (ОКПД2 21.20.10.141 – Препараты для лечения заболеваний сердца), 2 000 мл Закон: 44-ФЗ. Способ закупки: Электронный аукцион. Площадка: Электронная торговая площадка «Фабрикант». Начальная (максимальная) цена: 2 304 470.00 ₽. Организатор: ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ МОСКОВСКОЙ ОБЛАСТИ "МОСКОВСКИЙ ОБЛАСТНОЙ ОНКОЛОГИЧЕСКИЙ КЛИНИЧЕСКИЙ ЦЕНТР". Регион: Московская область. Приём заявок до: 09.11.2026 10:00 (МСК).

Извещение в ЕИС: https://zakupki.gov.ru/epz/order/notice/ea20/view/common-info.html?regNumber=0348200041326000552

Context for bidders

We hold 78 notices from ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ МОСКОВСКОЙ ОБЛАСТИ "МОСКОВСКИЙ ОБЛАСТНОЙ ОНКОЛОГИЧЕСКИЙ КЛИНИЧЕСКИЙ ЦЕНТР", going back to October 2026 — 43 of them still open. They buy mostly in Healthcare & Pharma, Manufacturing & Supply and Chemicals & Materials. There are 22,702 open Healthcare & Pharma tenders in Russia. This one closes in 10 days.

More from this buyer

Similar Healthcare & Pharma tenders

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Common bidding mistakes to avoid →Writing a winning proposal

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →